Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PK-SMART: Penetrating Keratoplasty With Sutureless Membrane Artificial Endothelial Replacement Technique. Report of the First Three Clinical Cases.

Cornea·2026
Same author

Distinct Ocular Surface Microbial Profiles in Corneal Transplant Candidates.

Cornea·2026
Same author

Random Copolyester-Based Delivery Systems for Tear Protein Therapeutics in Ocular Surface Disorders.

ACS omega·2026
Same author

Recent Developments in Tear Fluid Biomarkers: An Expert Perspective on Clinical Translation.

Current eye research·2026
Same author

Integrated Evaluation of Corneal Damage, Goblet Cell Remodeling and Inflammatory Response in a Murine Model of Environmental Dry Eye Disease (DED).

Biomedicines·2026
Same author

The Role of Innervation in Ocular Surface Homeostasis, Tissue Remodeling Following Nerve Injury, and the Therapeutic Potential of Hemocomponents in Neuronal and Cicatricial Pathologies.

Journal of clinical medicine·2026

Related Experiment Video

Updated: May 13, 2026

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
05:00

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

TearLab® Osmolarity System for diagnosing dry eye.

Piera Versura1, Emilio C Campos

  • 1Ophthalmology Unit, Alma Mater Studiorum University of Bologna, S. Orsola-Malpighi Teaching Hospital, Pad. 1 Palagi, Via Palagi 9, 40138 Bologna, Italy. piera.versura@unibo.it

Expert Review of Molecular Diagnostics
|March 13, 2013
PubMed
Summary

Dry eye disease diagnosis is improved by a new lab-on-a-chip device measuring tear osmolarity. This technology offers a rapid, reliable method for assessing ocular surface health in clinical practice.

More Related Videos

Optimizing Tear Collection in Mice for mRNA and Protein Analysis
09:04

Optimizing Tear Collection in Mice for mRNA and Protein Analysis

Published on: July 19, 2024

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

Published on: April 25, 2025

Related Experiment Videos

Last Updated: May 13, 2026

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
05:00

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

Optimizing Tear Collection in Mice for mRNA and Protein Analysis
09:04

Optimizing Tear Collection in Mice for mRNA and Protein Analysis

Published on: July 19, 2024

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

Published on: April 25, 2025

Area of Science:

  • Ophthalmology
  • Biomedical Engineering
  • Medical Diagnostics

Background:

  • Dry eye (DE) disease is a common ocular condition affecting the lachrymal unit.
  • Current diagnostic methods for DE severity often lack accuracy due to poor correlation between symptoms and clinical signs.
  • Tear osmolarity is a critical factor in the development and persistence of dry eye disease.

Purpose of the Study:

  • To review the characteristics and limitations of current dry eye diagnostic tests.
  • To explore the role of tear osmolarity in dry eye etiopathogenesis and measurement challenges.
  • To critically evaluate the diagnostic performance and clinical utility of a novel electrical impedance-based lab-on-a-chip technology for tear osmolarity measurement.

Main Methods:

  • Review of existing literature on dry eye disease, tear osmolarity, and diagnostic technologies.
  • Analysis of the principles behind electrical impedance-based lab-on-a-chip technology for tear osmolarity measurement.
  • Critical assessment of the diagnostic accuracy, reliability, and clinical applications of the reviewed technology.

Main Results:

  • The innovative lab-on-a-chip technology enables rapid and reliable measurement of tear osmolarity in a clinical setting.
  • This technology addresses limitations of current diagnostic tests for dry eye disease.
  • The device shows potential for objective assessment of ocular surface health.

Conclusions:

  • The electrical impedance-based lab-on-a-chip technology provides a promising tool for the objective assessment of tear osmolarity.
  • This technology can aid in defining dry eye severity and improving patient management.
  • Further scientific evidence is expected to establish its role in clinical trials and daily practice for ocular surface health.